ABOUT CASTOR
Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest-rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug-and-play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, eConsent, and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security, and reusability of data for researchers worldwide. For more information, visit www.castoredc.com.
FEATURED ARTICLES
-
Leveraging hyperspectral imaging and AI-driven analysis, Optina Diagnostics aims to revolutionize Alzheimer's diagnosis, offering hope for earlier intervention and improved outcomes.
-
Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.
-
This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.
-
Learn how incorporating "bother" as a patient-reported outcome metric aligns research with real-world experiences and drug development with patient needs.
-
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.
-
Discover how integrating Patient-Reported Outcomes can drive alignment with Value-Based Care (VBC) principles, enhancing product marketability and adoption while promoting patient health and quality of life.
-
Learn how evolving with AI could potentially lead to more streamlined, efficient, and innovative drug development processes.
-
Learn how having a comprehensive understanding of regulatory perspectives on AI ethics will prove invaluable for researchers evaluating the integration of AI technology into their trials.
-
Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.
-
Gain a better understanding of the primary challenges faced by the life sciences industry's commercial model in response to the updated EU MDR guidelines.
-
Explore a broader strategy for shortening clinical trial timelines that encompasses various elements, ranging from enhancing interoperability to implementing AI-driven technologies.
-
See how a global hygiene and health company was able to deploy virtual methods through a strategic partnership to recruit and retain participants, streamline consent, and analyze patient data.
-
Explore how biomarkers and digital endpoints address inefficiencies, significantly accelerating the pace of clinical trial processes, and have the potential to revolutionize medical research.
-
By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
Discover how innovative trial designs, the utilization of RWD and RWE, and the development of synthetic control arms are poised to drive advancements in the field of rare diseases.
-
As a result of trial design changes in the life sciences industry, learn what drug developers are doing to keep pace with the ongoing advancements in genomics, immunology, and precision medicine.
-
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
Understand the gaps between how data is collected in real-world evidence (RWE) and randomized clinical trials (RCT) and how RWE is quickly finding ways to catch up.
-
Discover ways that leveraged machine-to-machine devices connected directly to the Internet of Things could benefit clinical trials.
-
As wearables unleash new possibilities, the industry will need an effective strategy to utilize these useful tools. Consider these tips when incorporating wearables in a clinical study.
CONTACT INFORMATION
Castor
175 Varick St.
New York, NY 10014
UNITED STATES
Contact: Laura McLoughlin